Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lei, Kaijian
NCT05372120: A Clinical Trial of ICP-192 in Treated Patients With Advanced Solid Tumors With FGF/FGFR Gene Alterations	Recruiting	2	200	RoW	ICP-192	Beijing InnoCare Pharma Tech Co., Ltd.	Advanced Solid Tumor	12/23	06/24
NCT06434610: A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.	Recruiting	2	90	RoW	B013, Paclitaxel, Placebo	Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd	Platinum-resistant Recurrent Ovarian Cancer	12/26	12/26
NCT05126719: A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma	Recruiting	2	238	RoW	MRG003, Capecitabine tablets, Docetaxel injection	Shanghai Miracogen Inc.	Recurrent or Metastatic Nasopharyngeal Carcinoma	10/24	02/25
PM8002-A001, NCT05918445: PM8002 in the Treatment of Patients With Advanced Solid Tumors	Recruiting	1/2	380	RoW	PM8002	Biotheus Inc.	Malignant Neoplasm	11/25	11/25